Canakinumab Versus Placebo in Combination with First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results from the CANOPY-1 TrialDaniel S. W. Tan,Enriqueta Felip,Gilberto de Castro,Benjamin J. Solomon,Alastair Greystoke,Byoung Chul Cho,Manuel Cobo,Tae Min Kim,Sandip Ganguly,Enric Carcereny, Luis Paz-Ares,Jaafar Bennouna,Marina Chiara Garassino,Michael Schenker,Sang-We Kim,Jan C. Brase, Denise Bury-Maynard,Vanessa Q. Passos,Stephanie Deudon,Bharani Dharan,Yuanbo Song,Rafael Caparica,Bruce E. JohnsonJOURNAL OF CLINICAL ONCOLOGY(2024)引用 0|浏览23暂无评分关键词Non-Small Cell Lung Cancer,Combination TherapiesAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要